Prognosis
Roche, Illumina to Settle Decade-Long Fight Over Prenatal Tests
- Fight focused on blood tests for fetal abnormalities
- Landmark tests replaced invasive test on pregnant women
This article is for subscribers only.
Roche Holding AG and Illumina Inc. are on the verge of settling a nearly decade-long battle over a blood test that replaced a painful and sometimes dangerous test used to determine fetal abnormalities.
The companies “anticipate that a settlement will be signed by May 26,” Illumina lawyer Edward Reines of Weil Gotshal said in a court filing late Friday. The agreement was reached just as the Supreme Court was set to consider whether to wade into a debate over whether the technology underlying the tests could be patented.